This category covers end-to-end molecular data science: genome assembly, variant interpretation, transcriptome profiling, epigenome mapping, single-cell & spatial omics, metagenomics, and population genomics. It emphasizes reproducibility, FAIR principles, and clinically actionable insights.
This category builds deep expertise in protein structure analysis, molecular modeling and simulation, docking and free-energy methods, proteomics–genomics integration, and antibody informatics. It emphasizes validated, reproducible pipelines and publication-grade structural insights.
This category unifies statistical foundations with modern AI for omics and clinical data. It covers supervised and unsupervised learning, deep sequence models, graph and transformer architectures, privacy-preserving learning, reproducible pipelines, and cloud-scale deployment aligned with FAIR and research integrity principles.
Comprehensive training across amplicon and shotgun microbiome pipelines, MAG reconstruction, functional and taxonomic profiling, multi-omics integration, and ecosystem-scale modeling. Emphasis on compositional statistics, bias control, MIxS standards, and deployable workflows for clinical, agricultural, and environmental use-cases.
Patient-centric bioinformatics spanning clinical NGS, variant interpretation, pharmacogenomics, tumor–normal and liquid biopsy analytics, real-world evidence, and EHR/FHIR integration. Emphasis on clinical quality systems (CLIA/CAP) , regulatory compliance (HIPAA, 21 CFR Part 11) , and decision support for precision oncology, rare disease, and population screening programs.
An end-to-end track for small-molecule discovery: curated chemistry data, descriptor engineering, QSAR/QSPR (2D/3D) , pharmacophores, virtual screening, ADMET & PBPK modeling, synthesis planning, and modern AI for de novo design — all with rigorous benchmarking and reproducible pipelines.
End-to-end training to build, calibrate and validate mechanistic and data-driven models of cells and tissues: networks & GRNs, signaling, metabolic FBA/GEMs, ODE/SDE dynamics, agent-based systems, multi-omics integration, standards (SBML/SBGN) and reproducible model sharing for translational impact.
From experimental proteomics design and peptide-spectrum interpretation to structural modeling and atomistic simulations, this track builds end-to-end skill for quantitation, PTM biology, protein engineering, and mechanistic insights via docking, MD and free-energy workflows, aligned to reproducible and publication-grade outputs.
A complete track spanning NMR/LC–MS/GC–MS acquisition to rigorous peak processing, identification confidence, statistics, pathway enrichment, and multi-omics integration. Specialized lipidomics and isotope-tracing modules connect metabolite dynamics to network flux through MFA and constraint-based modeling with FAIR, repository-ready outputs.
End-to-end training for microbiome science across amplicon, shotgun, metatranscriptome and MAG-centric workflows. Focus on robust design, contamination control, compositional statistics, functional inference, AMR/resistome surveillance and One Health applications with FAIR, reproducible outputs.
This category provides integrative and computational frameworks to model, simulate, and analyze biological systems as networks of interactions. It focuses on understanding emergent properties, robustness, and perturbation responses across molecular, cellular, and organismal levels, connecting data-driven omics with mechanistic pathway models and predictive simulations.
An end-to-end track spanning ligand and structure-based design, QSAR/QSPR modeling, virtual screening, free-energy calculations, ADMET risk assessment and AI-driven de novo design. Emphasis on robust validation, interpretability, and decision-making for hit discovery and lead optimization with reproducible pipelines.
This track operationalizes genomics in healthcare: validated pipelines for WES/WGS and RNA-seq, clinical annotation and evidence frameworks, pharmacogenomics, oncology signatures, reporting standards, and compliance with quality systems and global regulatory pathways — from bench to bedside.
A rigorous path from study design and statistical foundations to modern ML/DL for multi-omics, with strong emphasis on validation, interpretability, reproducibility and operationalization. Build models that are not only accurate, but calibrated, auditable and deployable in regulated environments.
From structure acquisition and QC to modelling, docking, conformational analysis and in-silico design, this category unifies structural data with biophysical principles to explain function, engineer stability, and guide therapeutic or industrial protein design using reproducible, FAIR-ready workflows.
A complete journey from experimental design and data acquisition (LC-MS/MS, NMR) through processing, identification, statistics and biological interpretation. Includes lipidomics, isotope tracing for flux, quality systems, standards and FAIR data for publication and regulatory contexts.
A complete proteomics track from experimental strategy and instrument methods to search, quantification, PTM mapping and verification. Master DDA/DIA/PRM/SRM, robust FDR control, clinical assay build-outs and FAIR data packaging for PRIDE with multi-omics integration for biological interpretation.
A complete journey across glycan biology, experimental workflows for released glycans and intact glycopeptides, MS fragmentation logic, quantitative designs and informatics standards. Learn to identify, quantify and interpret glycan patterns with clinical, immunological and bioprocess relevance using FAIR and MIRAGE-compliant reporting.
Build end-to-end vaccine and immuno-analytics pipelines: epitope discovery, repertoire profiling, systems immunology, neoantigen mining and in-silico trials. Emphasis on population coverage, manufacturability, safety (allergenicity/toxicity) and regulatory readiness for translational deployment.
Build robust microbiome pipelines from sampling and sequencing through taxonomy, function, MAG recovery and strain tracking. Analyze longitudinal dynamics, networks and interventions, integrate meta-omics and deliver FAIR-compliant outputs for clinical, environmental and industrial use-cases.
Build predictive models that connect genes, proteins, pathways and phenotypes. Learn network inference, constraint-based and kinetic modeling, multi-scale simulation and digital twins. Emphasis on standards (SBML/SBOL/OMEX) , reproducibility, and decision-grade interpretation for research and translational use.
End-to-end structure-guided pipelines: model, dock, simulate and analyze biomolecular systems. Learn best practices for model quality, parameterization, MD production and free-energy analysis, with advanced sampling, membrane systems and experimental data–guided refinement for decision-grade insights.
Design, prioritize and de-risk small molecules with robust data curation, descriptor engineering, QSAR/QSPR, pharmacophore and multi-objective optimization. Translate models into ADME/Tox insight, exposure and risk, and produce FAIR, compliance-ready packages for discovery and development pipelines.
Build quantitative small-molecule pipelines from experimental design and acquisition to statistics, biological interpretation and FAIR outputs. Learn untargeted/targeted analysis, lipidome specialization, isotope tracing and flux modeling for mechanism and biomarker discovery across sectors.
Master protein-level analysis — from expression quantification to structure-function mapping using LC–MS/MS, PTM profiling, interactome discovery, and structural proteomics. Emphasis on DIA, crosslinking, HDX, and integrative multi-omics with FAIR, reproducible outputs.
Learn the analytical, computational and structural approaches to decode the glycome and its biological significance. This category trains in experimental glycan characterization, MS/NMR-based structure elucidation, glycoproteomics integration, and bioinformatics tools for glycobiology and biomarker research.
Develop end-to-end pipelines for amplicon, shotgun and long-read metagenomics; curate MAGs; quantify diversity, function and resistomes; and translate findings to clinical, industrial and environmental applications with FAIR data practices and reproducible analytics.
Build executable biological theories: reconstruct networks, formulate mechanistic models, calibrate against multi-omics, and translate to disease modules and patient-specific predictions. Emphasis on standards (SBML, SBGN) , reproducibility and decision-grade uncertainty analysis.
End-to-end structure determination and simulation: from crystallography, cryo-EM/ET, NMR and SAXS to homology/ab-initio modeling, docking, free-energy and MD with enhanced sampling. Emphasis on hybrid, integrative modeling, validation and decision-grade uncertainty.
Connect genotype to dose: interpret pharmacogenes, apply guideline-driven decisions, and leverage PK/PD, PBPK, PopPK and QSP to individualize therapy. This category bridges clinical PGx, model-informed drug development and bedside precision dosing with reproducible workflows.